Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,173.91
(
0.00%
)
US TECH 100
26,258.40
(
-1.17%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
104.41
(
2.25%
)
Bitcoin
76,133.97
(
-1.60%
)
News Focus
News Focus
Post# of 130217
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

RNsidersbuying

Send PM Follow Ignore
Followers 48
Posts 4769
Boards Moderated 0
Alias Born 07/26/2010

RNsidersbuying

Re: RNsidersbuying post# 77380

Thursday, 10/01/2020 3:18:30 PM

Thursday, October 01, 2020 3:18:30 PM

Post# of 130217
NBIO .065 - bullish writeup at biopharmajournal...

By Gavins Felicity -September 29, 2020

Nascent Biotech Inc. (OTCMKTS:NBIO) is a clinical stage biopharmaceutical company with a number of potential drivers and catalysts in play. Today, we take a look at recent analysis and company-specific factors, as well as the macro context, to provide a detailed examination of the stock and its prospects.

https://biopharmajournal.com/2020/09/29/why-nascent-biotech-inc-otcmktsnbio-is-worth-a-close-look
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today